Stocktwits on MSN
MBRX stock drops 25% as Moleculin Biotech's interim cancer trial data falls short of significance
The company said the independent safety board reviewing the study saw a clear trend favoring the Annamycin combination, though there was no statistical significance. ・Full data from the first part of ...
In a limited sample size from 2025, the stats show why the Packers are rolling with former 1st round pick Jordan Morgan at ...
THE growing use of artificial intelligence (AI) and other non-traditional data sources in official statistics must be backed by transparent methodologies and internationally accepted standards to ...
The leader of Australia's far-right One Nation party criticised the country's living standards in a June 2026 speech at the ...
Synthetic data is a vital substitute for real sensitive personal data in supporting social science research and policy ...
Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global ...
Both Annamycin dose arms outperformed control on the primary endpoint of complete remission (CR): 43% and 36% versus 12% — ...
After acquiring Milwaukee Bucks superstar in a trade last week, the Miami Heat roster has completely changed. The team dealt Tyler Herro, Kel'el Ware, Jaime Jaquez Jr. and Kasparas Jakucionis as part ...
It starts with what should be a happy moment: looking at your wedding dress. But for many brides, that moment is followed by ...
New research suggests that low handgrip strength alone is not a reliable predictor of increased prostate cancer risk among ...
Since 2024, pregnant moms in Flint have been able to get $7,500 through the Rx Kids program. New research shows what happened ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results